v3.25.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities    
Net Loss $ (642,266) $ (908,045)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 60,440 118,275
Stock-based compensation expense 72,252 65,440
Changes in operating assets and liabilities which used cash:    
Accounts receivable (4,003) 30,060
Prepaid expenses and other current assets 28,771 161,468
Accounts payable (6,051) 7,109
Accrued compensation 133,858 32,800
Deferred revenue (12,090) 24,375
Other accrued liabilities (46,676) (19,745)
Net cash and cash equivalents used in operating activities (415,765) (488,263)
Cash Flows from Investing Activities    
Investment in capitalized software (87,600) (148,000)
Net cash and cash equivalents used in investing activities (87,600) (148,000)
Net decrease in cash, cash equivalents, and restricted cash (503,365) (636,263)
Cash, cash equivalents, and restricted cash - Beginning of period 2,433,418 2,071,016
Cash, cash equivalents, and restricted cash - End of period 1,930,053 1,434,753
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:    
Issuance of common stock for public offering consulting expenses $ 655,000

Source